PICTET ASSET MANAGEMENT SA - C4 THERAPEUTICS INC ownership

C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 116 filers reported holding C4 THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.0%.

Quarter-by-quarter ownership
PICTET ASSET MANAGEMENT SA ownership history of C4 THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$11,448,000
+33.6%
1,305,349
+14.8%
0.02%
+41.7%
Q2 2022$8,572,000
-68.8%
1,136,854
+0.5%
0.01%
-61.3%
Q1 2022$27,449,000
-19.6%
1,131,441
+6.7%
0.03%
-8.8%
Q4 2021$34,152,000
-30.4%
1,060,628
-3.4%
0.03%
-37.0%
Q3 2021$49,077,0001,098,4210.05%
Other shareholders
C4 THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 1,642,210$14,402,0001.72%
Soleus Capital Management, L.P. 1,441,513$12,642,0001.72%
Nextech Invest Ltd. 375,857$3,296,0001.06%
RTW INVESTMENTS, LP 2,819,472$24,727,0000.57%
ArrowMark Colorado Holdings LLC 5,091,975$44,657,0000.55%
WASATCH ADVISORS LP 5,934,476$52,045,0000.36%
HARBOR CAPITAL ADVISORS, INC. 25,470$223,0000.20%
Perceptive Advisors 766,231$6,720,0000.20%
DRIEHAUS CAPITAL MANAGEMENT LLC 606,721$5,321,0000.08%
Virtus ETF Advisers LLC 19,305$169,0000.07%
View complete list of C4 THERAPEUTICS INC shareholders